Yu Yuping, Huang Jinyue, Chen Xiaofang, Fu Jia, Wang Xinhui, Pu Linjie, Gu Chunyu, Cai Chunquan
Graduate College of Tianjin Medical University, Tianjin, China.
Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, China.
Front Neurol. 2022 Mar 14;13:844117. doi: 10.3389/fneur.2022.844117. eCollection 2022.
Autism Spectrum Disorder is a neurodevelopmental disorder, with a rapid increase in recognition over the past decade. Interest in alternative therapies is growing annually, such as dietary therapies including gluten-free and/or casein-free diet, and the ketogenic diet. However, there is no consensus on the efficacy and safety of dietary therapy in children with ASD up to now. This study aimed to assess the efficacy and safety of these diet interventions for children with ASD based on a meta-analysis of global data.
Seven databases (Cochrane Library, PubMed, EMBASE, Web of Science, VIP, CNKI, and Wanfang) were searched according to the established inclusion criteria, from the inception of the databases to August 18, 2021. The Cochrane Bias risk assessment tool was intended to assess the quality of the included studies. Review Manager 5.4 software was used as an efficacy analysis tool of the included studies, taking the core autistic symptoms and scales of ASD as therapeutic efficacy evaluations.
In total, 7 RCTs with 338 participants were finally obtained. All studies assessed the association between core autistic symptoms and therapeutic diet, showing a statistically significant effect (standard mean difference (SMD) of -0.51, 95% confidence interval (Cl): -0.81 to -0.21), in which two studies which followed the GFD diet reported significant reductions in social behaviors (SMD of-0.41, 95% Cl: -0.75 to -0.06), showing no correlation with the length of the interventions ( < 0.05). Two studies were performed in KD diet suggested a significant effect in core symptoms (SMD of -0.67, 95% Cl: -1.04 to -0.31). No statistically significant changes were observed in the GFCF diet, GFD diet, cognition, communication, and stereotypical behaviors subgroups (all > 0.05).
The results of a meta-analysis suggest that diet therapies can significantly ameliorate core symptoms of ASD, and GFD diets are conducive to improving social behaviors. Although the results suggest the effectiveness of dietary therapy for ASD, limited by the small sample size of RCTs, more well-designed, and high-quality clinical trials are needed to validate the above conclusions.
https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42021277565.
自闭症谱系障碍是一种神经发育障碍,在过去十年中其诊断率迅速上升。对替代疗法的兴趣逐年增加,例如饮食疗法,包括无麸质和/或无酪蛋白饮食以及生酮饮食。然而,迄今为止,关于饮食疗法对自闭症谱系障碍儿童的疗效和安全性尚无共识。本研究旨在基于对全球数据的荟萃分析,评估这些饮食干预措施对自闭症谱系障碍儿童的疗效和安全性。
根据既定的纳入标准,检索了七个数据库(考克兰图书馆、PubMed、EMBASE、科学网、维普、中国知网和万方),检索时间从各数据库建库至2021年8月18日。采用考克兰偏倚风险评估工具评估纳入研究的质量。使用Review Manager 5.4软件作为纳入研究的疗效分析工具,将自闭症的核心症状和量表作为治疗效果评估指标。
最终共获得7项随机对照试验,涉及338名参与者。所有研究均评估了核心自闭症症状与治疗性饮食之间的关联,显示出统计学上的显著效果(标准化均数差(SMD)为-0.51,95%置信区间(Cl):-0.81至-0.21),其中两项采用无麸质饮食的研究报告社交行为有显著改善(SMD为-0.41,95%Cl:-0.75至-0.06),且与干预时间长短无关(P<0.05)。两项采用生酮饮食的研究表明对核心症状有显著效果(SMD为-0.67,95%Cl:-1.04至-0.31)。在无麸质和无酪蛋白饮食、无麸质饮食、认知、沟通和刻板行为亚组中未观察到统计学上的显著变化(均P>0.05)。
荟萃分析结果表明,饮食疗法可显著改善自闭症谱系障碍的核心症状,无麸质饮食有助于改善社交行为。尽管结果表明饮食疗法对自闭症谱系障碍有效,但受随机对照试验样本量较小的限制,需要更多设计良好、高质量的临床试验来验证上述结论。